Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when prescribed for other medical conditions. Exception requests from doctors may provide ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from ...

Access remains limited to these effective but expensive drugs, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.

New Jersey would lose about $3.6 billion a year in federal Medicaid funding, and more than 300,000 residents would risk ...

The North Carolina House of Representatives approved a budget plan on May 22 for the next two fiscal years that would cut ...

The agreements cap patients’ monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs ...

Medicare does not cover cosmetic liposuction ... Some people who wish to lose weight consider undergoing liposuction. However, most people lose only 2 to 5 pounds after having the procedure.

California's Medi-Cal program faces insolvency amid a $12 billion budget shortfall, with Republicans blaming illegal immigrant enrollments for the financial crisis.